Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Sarcoma 2Esophageal Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Diseases 1Skin Neoplasms 1Prolactinoma 1Pituitary ACTH Hypersecretion 1Paraproteinemias 1Pancreatic Ductal Adenocarcinoma 1Nervous System Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Lung Neoplasms 1Leiomyosarcoma 1Immunoglobulin Light-chain Amyloidosis 1Gigantism 1Endometrial Neoplasms 1Congenital Abnormalities 1Combined Pituitary Hormone Deficiency 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Central Nervous System Neoplasms 1Central Nervous System Diseases 1Carcinosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Curcumin 2Tissue Banks 1Probiotics 1Docosahexaenoic Acids 1Diet, Plant-Based 1Diet, Mediterranean 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Monoclonal Gammopathy of Undetermined Significance × Tissue Banks × Clear all
NCT01408225 2026-03-23

B-SCR-MM

Ohio State University Comprehensive Cancer Center

Recruiting
5,000 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡